GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,043,495 | -16.6% | 21,017 | 0.0% | 0.09% | -10.5% |
Q2 2023 | $1,251,353 | +5.1% | 21,017 | 0.0% | 0.10% | -3.7% |
Q1 2023 | $1,190,403 | -23.7% | 21,017 | 0.0% | 0.11% | -29.2% |
Q4 2022 | $1,560,933 | +24.7% | 21,017 | 0.0% | 0.15% | +14.9% |
Q3 2022 | $1,252,000 | +6.1% | 21,017 | 0.0% | 0.13% | +35.4% |
Q2 2022 | $1,180,000 | -23.9% | 21,017 | 0.0% | 0.10% | -8.3% |
Q1 2022 | $1,551,000 | -31.0% | 21,017 | -32.5% | 0.11% | -28.5% |
Q4 2021 | $2,249,000 | -7.2% | 31,149 | -1.5% | 0.15% | -15.2% |
Q3 2021 | $2,423,000 | -0.6% | 31,624 | +0.6% | 0.18% | +1.7% |
Q2 2021 | $2,438,000 | +25.7% | 31,449 | 0.0% | 0.18% | +14.4% |
Q1 2021 | $1,939,000 | -5.5% | 31,449 | 0.0% | 0.15% | -11.0% |
Q4 2020 | $2,051,000 | +29.6% | 31,449 | -1.6% | 0.17% | +17.8% |
Q3 2020 | $1,582,000 | +3.8% | 31,949 | 0.0% | 0.15% | -3.3% |
Q2 2020 | $1,524,000 | +15.5% | 31,949 | +2.9% | 0.15% | -13.7% |
Q1 2020 | $1,320,000 | -27.8% | 31,042 | 0.0% | 0.18% | -1.7% |
Q4 2019 | $1,828,000 | +15.2% | 31,042 | 0.0% | 0.18% | +3.5% |
Q3 2019 | $1,587,000 | +20.9% | 31,042 | 0.0% | 0.17% | +22.0% |
Q2 2019 | $1,313,000 | -14.4% | 31,042 | 0.0% | 0.14% | -24.6% |
Q1 2019 | $1,534,000 | +14.2% | 31,042 | 0.0% | 0.19% | -11.4% |
Q4 2018 | $1,343,000 | -24.0% | 31,042 | -0.3% | 0.21% | +26.3% |
Q3 2018 | $1,768,000 | +12.5% | 31,142 | 0.0% | 0.17% | +9.2% |
Q2 2018 | $1,571,000 | +1.4% | 31,142 | +0.2% | 0.15% | -4.4% |
Q1 2018 | $1,549,000 | +21.4% | 31,087 | +0.1% | 0.16% | -3.0% |
Q4 2017 | $1,276,000 | +38.2% | 31,042 | 0.0% | 0.16% | +36.4% |
Q3 2017 | $923,000 | -10.3% | 31,042 | 0.0% | 0.12% | -10.4% |
Q2 2017 | $1,029,000 | +12.0% | 31,042 | 0.0% | 0.14% | +12.5% |
Q1 2017 | $919,000 | +19.4% | 31,042 | 0.0% | 0.12% | +23.7% |
Q4 2016 | $770,000 | +9.8% | 31,042 | 0.0% | 0.10% | +3.2% |
Q3 2016 | $701,000 | -5.3% | 31,042 | 0.0% | 0.09% | 0.0% |
Q2 2016 | $740,000 | +0.4% | 31,042 | 0.0% | 0.09% | +4.4% |
Q1 2016 | $737,000 | -14.7% | 31,042 | 0.0% | 0.09% | -8.2% |
Q4 2015 | $864,000 | – | 31,042 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |